|
National Consultation
on the Need and Feasibility of Second line ARV Drugs
24-25 Nov 2005
 The
National AIDS Control Organization (NACO) with support from WHO India, convened a national
consultation on the need and feasibility of providing second line ARV drugs
within the national ART programme.
The 2-day consultation brought together a broad range of experts from major
partners such as CDC and Clinton Foundation; NGOs such as YRG Care; Freedom
Foundation; Medecins Sans
Frontieres; Lawyers
Collective; INP+; MoH
(WTO Cell); ART physicians; laboratory experts; patent law and public health
specialists; to discuss technical and operational aspects in relation to the
need and feasibility of having second line ARV drugs. Recommendations have
been made and a report will be available soon.
|
